Remodeless CV Ltd.

Developing therapeutic solutions for cardiovascular diseases, focusing on the heart, brain, and blood vessels.

Biotechnology
Active
Ra'anana, Israel Founded 2019
Website ↗
Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2019
Headcount
—
HQ
Ra'anana, Israel
Sector
Biotechnology

About

Remodeless CV is an Israeli company focused on developing therapeutic solutions for cardiovascular diseases. Their work aims to mitigate reperfusion injury, which is a common and often untreated phenomenon in acute cardiovascular events like myocardial infarction and ischemic strokes. The company's approach is designed to reduce heart failure rates post-MI, minimize neurological damage after ischemic strokes, and enhance the viability of transplanted organs. They have a robust portfolio of US and European patents.

Q&A

What is Remodeless CV Ltd.'s primary focus?
Remodeless CV Ltd. is an Israeli company focused on developing therapeutic solutions for cardiovascular diseases, specifically aiming to mitigate reperfusion injury in acute cardiovascular events like myocardial infarction and ischemic strokes.
What is the company's main objective with its therapeutic solutions?
The company's approach is designed to reduce heart failure rates post-myocardial infarction, minimize neurological damage after ischemic strokes, and enhance the viability of transplanted organs.
When was Remodeless CV Ltd. founded?
Remodeless CV Ltd. was founded in 2019.
Where is Remodeless CV Ltd. headquartered?
Remodeless CV Ltd. is headquartered in Ra'anana, Israel.
Who is the founder of Remodeless CV Ltd.?
The founder of Remodeless CV Ltd. is Jacob Schneiderman.
In which sector does Remodeless CV Ltd. primarily operate?
Remodeless CV Ltd.'s primary sector is Biotechnology.
Does Remodeless CV Ltd. hold any patents?
Yes, Remodeless CV Ltd. has a robust portfolio of US and European patents.

Team · 1

Jacob Schneiderman
Founder · Founder

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)